Evidence map›Paper›PMID 16177377›Full record

ArticleInfection and immunity2005

Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi.

Christine A Petersen, Katherine A Krumholz, Barbara A Burleigh

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Toll-like receptors in cardiac hypertrophy.Frontiers in cardiovascular medicine · 2023
    Review
  2. Review
  3. Frontiers in cellular and infection microbiology · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes.American journal of physiology. Cell physiology · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christine A PetersenDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Katherine A Krumholz
Barbara A Burleigh
Harvard University · US

Funding

Trypansoma cruzi-induced host cell signaling responsesR01AI047960 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BURLEIGH, BARBARA A · 2000 to 2009
$2.8M
Trypanosoma cruzi-elicited cardiac hypertrophyK08AI050803 · NIAID · IOWA STATE UNIVERSITY · PI PETERSEN, CHRISTINE A · 2002 to 2004
$285k
NIAID NIH HHS K08 AI050803NIAID NIH HHS K08 AI50803NIAID NIH HHS R01 AI047960NIAID NIH HHS R01 AI47960
6 · The paper itself

Abstract

Trypanosoma cruzi, the intracellular protozoan parasite that causes Chagasic cardiomyopathy, elicits a robust hypertrophic response in isolated cardiomyocytes. Previous studies established that T. cruzi-elicited cardiomyocyte hypertrophy is mediated by interleukin-1beta produced by infected cardiomyocyte cultures. Here, we define key upstream signaling events leading to cardiomyocyte hypertrophy in response to T. cruzi infection, to be dependent on Toll-like receptor 2 and NF-kappaB. Furthermore, we demonstrate that cardiomyocyte hypertrophy, which is initiated by live infective T. cruzi trypomastigotes or stimulation of isolated myocytes with secreted/released trypomastigote molecules, is a common outcome of the cardiomyocyte recognition of pathogen-associated molecular patterns by intrinsic Toll-like receptors. This study is the first to link pathogen recognition by intrinsic Toll-like receptors to cardiomyocyte hypertrophy.

Indexed as

Trypanosoma cruziAnimalsCells, CulturedCell SizeInterleukin-1Myocytes, CardiacNF-kappa BRatsSignal TransductionInterleukin-1NF-kappa B

Identifiers

PMID16177377
PMCPMC1230932
OpenAlexW2153992771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.